Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Emergency funding for COVID-19 studies not requiring clinical trials

Date added: 05 May 2020

Projects should carry out on rapid research into fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures.

Amount
Up to $275.000 (USD)
Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher education institutions, non-profit organisations, SMEs, for-profit organisations, governments

Foreign participation? (where known)
Yes

Epidemic Preparedness: COVID-19

Date added: 23 Apr 2020

This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.

Amount
Up to £2M
Agency or Funder
Wellcome Trust & UK Department for International Development (DFID)
Eligibility (if available)

PhD plus significant postdoctoral experience in an academic research organisation, a not-for-profit or government body, a private sector organisation

Foreign participation? (where known)
Yes

Prevention and combat of outbreaks, endemics, epidemics and pandemics

Date added: 23 Apr 2020

Support for postgraduate researchers in fields such as epidemiology, infection, microbiology, immunology, bioengineering and bioinformatics.

Amount
R$70M
Agency or Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Eligibility (if available)

Researchers of post-graduate program coordinated by CAPES

Foreign participation? (where known)
No
Date application deadline

A Swiss funding call for research on COVID-19 diagnostics, immunology and interventions

Date added: 23 Apr 2020

Support for researchers from four partner universities in Switzerland on diagnostics, human immune response, medical interventions and disease management.

Amount
0.5M to 2.5M CHF
Agency or Funder
Botnar Research Centre for Child Health (BRCCH) at University of Basel & ETH Zurich
Eligibility (if available)

Researchers from its four partner institutions (University of Basel, ETH Zurich, University Children’s Hospital Basel and Swiss Tropical and Public Health Institute)/ Multi-institutional consortia and collaborations with national or international researchers are encouraged.

Foreign participation? (where known)
Yes
Date application deadline

Grants available for researchers in Belgium

Date added: 23 Apr 2020

Funding to support reasearchers from FNRS and universities of the Wallonia-Brussels Federation. Priorities lie on epidemiological and translational studies, immunology and prevention of the virus.

Amount
€60,000
Agency or Funder
Fonds de la Recherche Scientifique (FNRS)
Eligibility (if available)

Researchers from FNRS or the six universities part of the Wallonia-Brussels Federation (ULB, UCLouvain, ULiege, UMons, UNamur, USL)

Foreign participation? (where known)
Yes
Date application deadline

COVID-19 in haematology

Date added: 05 May 2020

Proposals should address COVID-19 infection in malignant and benign haematologic disorders or haematological and immunological manifestations in COVID-19 infection.

Amount
€120.000
Agency or Funder
European Hematology Association
Eligibility (if available)

Home or host institute must be in Europe

Foreign participation? (where known)
Yes
Date application deadline

Preventing and managing epidemics in Brazil

Date added: 06 May 2020

Funding for Brazilian research and doctoral studies in epidemiology, immunology, pharmaceuticals sciences, telemedicine, and medical data analysis.

Amount
Up to 345.000 BRL with total funding of 70M BRL
Agency or Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Eligibility (if available)

Masters and doctoral students

Foreign participation? (where known)
No
Date application deadline

Swiss national COVID-19 research programme

Date added: 08 May 2020

Projects must advance the understanding of COVID-19 and the development of vaccines, therapeutics, and diagnostics. Multidisciplinary collaborations and use of international research networks are encouraged.

Amount
CHF 20M
Agency or Funder
Swiss National Science Foundation
Eligibility (if available)

Independent researchers holding a PhD or equivalent

Foreign participation? (where known)
Yes
Date application deadline

Basic research and COVID-19

Date added: 15 May 2020

Projects must cover relate to medical and biological problems or economic and educational aspects of the pandemic.

Amount
BGN1.8M
Agency or Funder
Bulgarian National Science Fund
Eligibility (if available)

Scientific organisations and higher education institutions

Foreign participation? (where known)
No
Date application deadline

Free transnational access to high containment facilities

Date added: 15 Jun 2020

Researchers investigating COVID-19 can get free access to high containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Free transnational access to high-containment facilities

Date added: 19 Jun 2020

Researchers investigating COVID-19 can get free access to high-containment research facilities, resources and services across Europe.

Amount
Access to high containment facilities
Agency or Funder
The European Research Infrastructure on Highly pathogenic Agents
Eligibility (if available)

Researchers or teams of researchers from anywhere

Foreign participation? (where known)
Yes
Date application deadline

Support for preclinical research into countermeasures against COVID-19

Date added: 23 Apr 2020

Support for the preclinical development of therapeutics or vaccines to fight infectious diseases/pathogens such as SARS-CoV-2. (Clinical trials will not be supported.)

Amount
$4,050,000 (U.S. dollars)
Agency or Funder
National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Higher Education Institutions, Nonprofits and For-Profit Organizations,State Governments ini the US.

Date application deadline

NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak

Date added: 23 Apr 2020

Research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID
Eligibility (if available)

Grantees currently supported by active NIH (National Institute of Allergy and Infectius Diseases) funding

Date application deadline

Rapid response call for UK-led research into COVID-19

Date added: 29 Apr 2020

UKRI calls for projects with potential to deliver a significant contribution to the understanding, prevention or management of the COVID-19 outbreak within 12 months.

Amount
UK - 80% of full economic costs. Overseas - 100% direct costs only
Agency or Funder
UK Research and Innovation and the Department of Health and Social Care
Eligibility (if available)

Principal investigator must be hosted by an institution eligible for UKRI funding.

Foreign participation? (where known)
Yes
Date application deadline